Fennec Pharmaceuticals Inc. Common Stock (FENC)

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Fennec Pharmaceuticals Inc. Common Stock (FENC) is listed on Nasdaq, where it has traded since January 28, 2002.

Listed On
Nasdaq
Listed Since
January 28, 2002
Employees
35
Market Cap
$342M

About Fennec Pharmaceuticals Inc. Common Stock

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Institutional ownership

In 13F filings for the quarter ended June 30, 2026, 102 institutions reported holding FENC, with 16.3 million shares worth $175.1 million in aggregate. The largest reported holder was Rosalind Advisors, with 3.2 million shares worth $34.3 million. Of the 5 largest holders listed below, 4 added shares and 1 reduced its position during the quarter.

InstitutionSharesValueQuarter change
Rosalind Advisors3,188,001$34MAdded 9.62%
Aigh Capital Management2,486,038$27MAdded 25.46%
Solas Capital Management1,889,366$20MReduced 23.88%
BlackRock1,727,069$19MAdded 26.23%
Awm Investment Company1,160,296$12MAdded 61.12%

Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.

Frequently asked questions

What is FENC?

Fennec Pharmaceuticals Inc. Common Stock (FENC) is listed on Nasdaq, where it has traded since January 28, 2002.

Who are the largest institutional holders of FENC?

In 13F filings for the quarter ended June 30, 2026, the largest reported holders of FENC were Rosalind Advisors, Aigh Capital Management and Solas Capital Management.

How many institutions own FENC?

102 institutions reported a position in FENC for the quarter ended June 30, 2026, worth $175.1 million in total.

Did institutions buy or sell FENC last quarter?

Of the 5 largest reported holders, 4 added shares and 1 reduced its position during the quarter. Every reported holder and its change is on the SentiSense ownership page for FENC.

Every reported institutional holder, plus insider and congressional trades in FENC, on SentiSense.